Top Institutions in Pediatric Dermatology
Leading institutions in pediatric dermatology and immunodermatology conduct randomized controlled trials, longitudinal cohort studies, and translational research to evaluate novel biologic therapies such as lebrikizumab for atopic dermatitis in children. Their expertise includes clinical trial design, pediatric patient management, and immunologic biomarker analysis.
-
#1
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
NIAID leads extensive research on atopic dermatitis pathophysiology and biologic therapies, including pediatric populations, and supports large-scale clinical trials through the NIH network.
Key Differentiators
- Pediatric Dermatology
- Immunology
- Clinical Trials
-
#2
Children’s Hospital of Philadelphia (CHOP)
Philadelphia, PA
CHOP is a leader in pediatric dermatology clinical trials and translational research, with a strong focus on atopic dermatitis and novel therapeutic agents including biologics.
Key Differentiators
- Pediatric Dermatology
- Clinical Research
-
#3
Stanford University School of Medicine
Stanford, CA
Stanford has a robust immunodermatology program with expertise in pediatric skin diseases and biologic therapies, contributing to clinical trials and mechanistic studies of atopic dermatitis.
Key Differentiators
- Dermatology
- Pediatric Dermatology
- Immunology
-
#4
Massachusetts General Hospital (MGH) Dermatology
Boston, MA
MGH Dermatology conducts leading clinical research in atopic dermatitis, including pediatric populations, and has expertise in biologic treatment development and safety monitoring.
Key Differentiators
- Dermatology
- Pediatric Dermatology
- Clinical Trials
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong pediatric dermatology division with active research in immune-mediated skin diseases and clinical trials of emerging biologics for atopic dermatitis.
Key Differentiators
- Pediatric Dermatology
- Immunodermatology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
